A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 Diabetes

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

This randomized, parallel group study will determine whether the use of episodic, intensive glucose monitoring via the Accu-Chek 360 view blood glucose analysis system has a positive effect on overall glycemic control. Patients will be randomized into either the 'usual care' group, or the 'interventional group' supplemented with the Accu-Chek 360 view blood glucose analysis system. The effect of each treatment regimen on glycemic control will be assessed by measurement of change in baseline HbA1c values at 12 months. The anticipated time on study treatment is 1 year, and the target sample size is 504 individuals.

Key facts

Study ID

NCT00674986

Run by

Hoffmann-La Roche

People needed

522

Starts

2008-03-01

Expected to finish

2010-02-01

Last updated by the study team

2013-10-21

Who can join

Age: 25 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients >= 25 years of age
• Type 2 diabetes for >= 1 year
• Hemoglobin A1c >= 7.5% and <=11%
• Diabetes managed by exercise and diet, prescription oral medication or an injectable incretin mimetic

You may not qualify if…

• Type 1 diabetes
• On any type of insulin therapy at start of study

Where it is running

• Study site — Mobile, Alabama, United States
• Study site — Pell City, Alabama, United States
• Study site — Chipley, Florida, United States
• Study site — Marianna, Florida, United States
• Study site — Pembroke Pines, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Atlanta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — O'Fallon, Illinois, United States
• Study site — Fishers, Indiana, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Flint, Michigan, United States
• Study site — Hickory, North Carolina, United States
• Study site — Raleigh, North Carolina, United States
• Study site — Wilmington, North Carolina, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Cuyahoga Falls, Ohio, United States
• Study site — Zanesville, Ohio, United States
• Study site — Pottstown, Pennsylvania, United States
• Study site — Pottstown, Pennsylvania, United States
• Study site — High Point, South Carolina, United States
• Study site — Lancaster, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.